Literature DB >> 7522188

Vascular cell adhesion molecule-1 expressed by peritoneal mesothelium partly mediates the binding of activated human T lymphocytes.

S A Cannistra1, C Ottensmeier, J Tidy, B DeFranzo.   

Abstract

Adhesion molecules such as selectins and integrins are known to mediate leukocyte attachment and transmigration through activated vascular endothelium. However, the molecules that mediate subsequent leukocyte entry into nonvascular spaces such as the abdominal cavity during states of peritoneal inflammation have not been identified. Because the peritoneal mesothelial lining represents the final barrier to leukocyte migration into the abdomen, it is likely that adhesion molecules expressed by mesothelial cells are involved in this process. We have developed an in vitro binding assay using confluent layers of normal human mesothelial cells to determine which adhesion molecules might be involved in T lymphocyte-mesothelial recognition. Normal peripheral blood T lymphocytes exhibit low-level specific binding to mesothelium (mean 13% specific binding, n = 4), which is enhanced by phorbol myristate acetate (PMA) treatment (mean 38% specific binding, n = 4). This binding is significantly inhibited in the combined presence of antibodies reactive with CD29 and CD18, suggesting a role for beta 1 and beta 2 integrins, respectively, in this interaction. Interestingly, cultured human mesothelial cells were shown to express vascular cell adhesion molecule-1 (VCAM-1), suggesting that this molecule might function as a counter-receptor for alpha 4 beta 1 expressed by T lymphocytes. Mesothelial cells were also noted to express ICAM-1, CD29, and CD44, but not CD18 or selectins. VCAM-1 expression was not a constitutive property of freshly obtained mesothelial cells but was inducible upon culture in the presence of either interleukin-1 (IL-1), tumor necrosis factor (TNF), or PMA. Neutralizing antibodies reactive with either alpha 4, VCAM-1, or CD29 were all equally capable of inhibiting the binding of activated leukocytes to mesothelial cells (in the presence of anti-CD18 antibody). Mesothelial VCAM-1 was found to have a molecular mass of 110 kD and an mRNA transcript of approximately 3.2 kb, consistent with the predominant VCAM-1 species found in activated endothelium. These data suggest that functional VCAM-1 is expressed on activated mesothelial cells and may play a role in the distal arm of leukocyte trafficking to the abdominal cavity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7522188

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  11 in total

1.  Screening of biomedical polymer biocompatibility in NMRI-mice peritoneal cavity: a comparison between ultra-high-molecular-weight polyethylene (UHMW-PE) and polyethyleneterephthalate (PET).

Authors:  K G Dahmen; N Maurin; H A Richter; C Mittermayer
Journal:  J Mater Sci Mater Med       Date:  1997-05       Impact factor: 3.896

2.  Imaging VCAM-1 as an indicator of treatment efficacy in metastatic ovarian cancer.

Authors:  Jennifer M Scalici; Stephanie Thomas; Christine Harrer; Timothy A Raines; Joanna Curran; Kristen A Atkins; Mark R Conaway; Linda Duska; Kimberly A Kelly; Jill K Slack-Davis
Journal:  J Nucl Med       Date:  2013-09-12       Impact factor: 10.057

Review 3.  Peritoneal damage: the inflammatory response and clinical implications of the neuro-immuno-humoral axis.

Authors:  Tarik Sammour; Arman Kahokehr; Mattias Soop; Andrew G Hill
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

4.  Inhibition of NF-kappaB with Dehydroxymethylepoxyquinomicin modifies the function of human peritoneal mesothelial cells.

Authors:  Patrycja Sosińska; Ewa Baum; Beata Maćkowiak; Ryszard Staniszewski; Tomasz Jasinski; Kazuo Umezawa; Andrzej Bręborowicz
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

Review 5.  New radiotracers for imaging of vascular targets in angiogenesis-related diseases.

Authors:  Hao Hong; Feng Chen; Yin Zhang; Weibo Cai
Journal:  Adv Drug Deliv Rev       Date:  2014-07-30       Impact factor: 15.470

6.  Morphological analysis of leucocyte transmigration in the pleural cavity.

Authors:  R Teng; K Johkura; N Ogiwara; X Zhao; L Cui; I Iida; Y Okouchi; K Asanuma; K Sasaki
Journal:  J Anat       Date:  2003-10       Impact factor: 2.610

7.  Inhibition of α4β1 integrin increases ovarian cancer response to carboplatin.

Authors:  Jennifer M Scalici; Christine Harrer; Anne Allen; Amir Jazaeri; Kristen A Atkins; Karen R McLachlan; Jill K Slack-Davis
Journal:  Gynecol Oncol       Date:  2013-12-28       Impact factor: 5.482

8.  Hyaluronan-positive plasma membrane protrusions exist on mesothelial cells in vivo.

Authors:  Ville Koistinen; Tiina Jokela; Sanna Oikari; Riikka Kärnä; Markku Tammi; Kirsi Rilla
Journal:  Histochem Cell Biol       Date:  2016-01-28       Impact factor: 4.304

Review 9.  Sterile Injury Repair and Adhesion Formation at Serosal Surfaces.

Authors:  Simone N Zwicky; Deborah Stroka; Joel Zindel
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

Review 10.  Mesothelial cells in tissue repair and fibrosis.

Authors:  Steven E Mutsaers; Kimberly Birnie; Sally Lansley; Sarah E Herrick; Chuan-Bian Lim; Cecilia M Prêle
Journal:  Front Pharmacol       Date:  2015-06-09       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.